Looking deeply, thinking broadly
Prime Genomics is developing new biofluid-based molecular diagnostic tests that will make breast cancer detection more accurate, efficient, accessible and affordable for women anywhere.
Looking deeply, thinking broadly
Prime Genomics is developing new biofluid-based molecular diagnostic tests that will make breast cancer detection more accurate, efficient, accessible and affordable for women anywhere.
Prime Genomics’ noninvasive biofluid approach is:
Clearly different
100%
OF WOMEN
Appropriate for all women, including
the ~50% with high density breasts
for whom imaging is inadequate.
Clearly needed
5.7M
CALL-BACKS EACH YEAR IN US
More precise detection eliminates
millions of follow-up appointments
and invasive procedures.
Clearly faster
2-3
MONTH TIME FROM SCREEN TO DIAGNOSIS
Streamlines the multi-step process
and reduces false positives,
delays, and patient anxiety.
Clearly accessible
ALL
PATIENTS
True non-invasive testing increases
access and compliance, and helps
address current disparities in care.
Clinical Research Programs
Prime Genomics partners with leading clinicians, cancer care communities and imaging centers to validate our breakthrough cancer detection methods.
We are actively enrolling patients in studies to evaluate a non-invasive breast cancer detection test designed to benefit all women. This new test examines underlying molecular signals in cancer.
For physicians interested in learning more about participating in our Clinical Programs, please contact us at: clinical@primegenomics.com
This test is in development. It has not been evaluated by the FDA, and is not yet available for sale in the U.S.
Careers
Are you interested in working with a fast-paced genomic medicine startup creating breakthrough diagnostic tests for meaningful improvements to healthcare?
Join us and be the change that will make noninvasive, effective and precise cancer testing possible for millions of women in the US and billions of women globally.
Prime Genomics is looking for high-performing, team-oriented genomic and technology development scientists, data analysts, and biotechnology leaders.
See our open opportunities or contact us directly to learn more.
Careers
Are you interested in working with a fast-paced genomic medicine startup creating breakthrough diagnostic tests for meaningful improvements to healthcare?
Join us and be the change that will make noninvasive, effective and precise cancer testing possible for millions of women in the US and billions of women globally.
Prime Genomics is looking for high-performing, team-oriented genomic and technology development scientists, data analysts, and biotechnology leaders.
See our open opportunities or contact us directly to learn more.
Press Release
- Prime Genomics Welcomes Robert Weigle as CEO, Oct 29, 2020
Contact
Prime Genomics is an emerging precision healthcare company based in the heart of Silicon Valley, California. We are a team of accomplished innovators in molecular diagnostics, genomics, and advanced data science who believe that groundbreaking changes to healthcare are possible.
Prime Genomics, Inc.
319 N. Bernardo Avenue
Mountain View, CA 94041
See on map
info@primegenomics.com